Abiopharma

🔍 Yao Huiwen (Executive)

Company: AST SpaceMobile, Inc. (ASTS)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 40,000 shares of Class A Common Stock at $0.0641 per share (Direct)
  Date: 2026-08-19 | Code: X | equity_swap_involved: 0 | shares_owned_after: 74,750.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 40,000 shares of AST LLC Incentive Equity Options at $0.0641 per share (Derivative)
  Date: 2026-08-19 | Code: X | Expires: 2029-04-17 | Exercise: 2023-10-01 | equity_swap_involved: 0 | shares_owned_after: 219,912.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Represents shares of Class A Common Stock obtained from exercise of AST LLC Incentive Equity Options.
• F2: Six months after vesting, each AST LLC Incentive Equity Option is exercisable for an AST LLC Incentive Equity Unit, each of which is then exchangeable for an AST LLC Common Unit that is redeemable for one share of Class A Common Stock. The AST LLC Incentive Equity Options expire no later than 10 years from the date of grant.